Transarterial chemoembolization versus sorafenib in patients with
hepatocellular carcinoma and extrahepatic disease
DOI: 10.1177/2050640617716597
Arndt Vogel,
Arndt Weinmann,
Frank Wacker,
Harald Ittrich,
Henning Wege,
Jan B Hinrichs,
Jens Marquardt,
Marcus-Alexander W？rns,
Martha M Kirstein,
Michael P Manns,
Nora Schweitzer,
Roman Kloeckner,
Thomas Rodt,
Thorben W Fründt,
Torsten Voigtl？nder
Keywords: Hepatocellular carcinoma, TACE, extrahepatic disease, metastases, sorafenib, advanced, BCLC
Abstract:
Full-Text
